Work

Octreotide is the favorable alternative for cisplatin resistance reversal of ovarian cancer in vitro and in nude mice in vivo.

Year: 2012
Type: article
Source: PubMed
Language: English
Field: Medicine
Open Access status: closed
OpenAlex ID: W2397081895
FWCI: 0.327
Cites:
Cited by: 6
Related to: 10